FDG/PET in CLL today
- PMID: 24786452
- DOI: 10.1182/blood-2014-03-563700
FDG/PET in CLL today
Abstract
In this issue of Blood, Falchi et al present their experience with 2-deoxy-2-[18F] fluoroglucose/positron emission tomography (FDG/PET) in the management of patients with chronic lymphocytic leukemia (CLL) or Richter syndrome (RS) over a 10-year period at a referral center. The results of this study shed light on the potential role of FDG/PET in CLL.
Comment on
-
Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia.Blood. 2014 May 1;123(18):2783-90. doi: 10.1182/blood-2013-11-536169. Epub 2014 Mar 10. Blood. 2014. PMID: 24615780 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources

